U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915402) titled 'Efficacy and Safety of "LMW - CL - HA - FACE/BODY" for the Augmentation of the Cheeks' on March 27.
Brief Summary: Midface volume loss is a typical sign of facial aging. Age-related loss of subcutaneous fullness in the malar prominence results in a less healthy facial proportion. Indeed, the primary goal in any rejuvenation procedure should be to restore the balanced distribution of facial fullness that characterizes the youthful face. Rejuvenating treatments of the cheeks have a significant effect on an overall appearance and on neighbouring periorbital area, making additional treatments unnecessary. Innovative techniques to restor...